Novartis
NVS
#57
Rank
A$381.77 B
Marketcap
A$198.97
Share price
-0.20%
Change (1 day)
29.84%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total debt

Total debt on the balance sheet as of September 2025 : A$48.20 Billion

According to Novartis's latest financial reports the company's total debt is A$48.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novartis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$50.25 B29.95%
2023-12-31A$38.67 B-5.7%
2022-12-31A$41.01 B-4.16%
2021-12-31A$42.79 B-13.07%
2020-12-31A$49.23 B18.25%
2019-12-31A$41.63 B-8.61%
2018-12-31A$45.55 B25.11%
2017-12-31A$36.40 B10.8%
2016-12-31A$32.85 B9.3%
2015-12-31A$30.06 B20.85%
2014-12-31A$24.87 B23.86%
2013-12-31A$20.08 B5.81%
2012-12-31A$18.98 B-3.79%
2011-12-31A$19.72 B-12.65%
2010-12-31A$22.58 B45.89%
2009-12-31A$15.48 B55.27%
2008-12-31A$9.97 B55.87%
2007-12-31A$6.39 B-30.11%
2006-12-31A$9.15 B-18.41%
2005-12-31A$11.21 B32.39%
2004-12-31A$8.47 B15.14%
2003-12-31A$7.36 B-20.85%
2002-12-31A$9.29 B3.94%
2001-12-31A$8.94 B33.18%
2000-12-31A$6.71 B-29.15%
1999-12-31A$9.48 B-10.38%
1998-12-31A$10.58 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
A$62.28 B 29.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.60 B 90.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 43.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$38.43 B-20.27%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$35.92 B-25.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$25.70 B-46.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
A$76.84 B 59.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B-59.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$49.12 B 1.90%๐Ÿ‡ฌ๐Ÿ‡ง UK